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Patients with heart failure have multiple risk 
factors for thromboembolic events, such as blood stasis in 
the lower limbs and heart chambers1, endothelial injury, 
and hypercoagulability2. Clinically, these phenomena are 
reflected in the high frequency of thromboembolic events 
with a significant impact on morbidity and mortality; in this 
sense, it has been reported that heart failure may increase 
the chances of cerebrovascular accidents up to 4.3 times3; 
additionally, ventricular thrombi are found in up to 49% of 
the autopsies of patients with dilated cardiomyopathy, and 
mural thrombi have been described in 68% of the patients 
with ventricular aneurysms4.
Despite the fact that the risk for thromboembolic 
events is increased throughout the heart failure population, 
some clinical conditions may offer additional risk. Patients 
with atrial fibrillation and those with Chagas disease, 
for instance, have a greater risk for the occurrence of 
thromboembolic events.
Autopsies are considered the “gold standard” in 
terms of providing the most definitive data on diagnostic 
accuracy, and have been used to compare in vivo and 
postmortem diagnoses5. Previous analyses indicate that 
diagnostic discrepancies remain high, even in the face of 
advances in diagnostic techniques6,7; these findings are 
sustained when data are adjusted for time and geographical 
variations8. 
Therefore, we hypothesized that thromboembolic 
findings are frequent in patients with heart failure and 
sought to analyze the presence of these findings in patients 
after autopsy.
In order to do so, we designed a retrospective study 
based on the analysis of 1457 autopsies reports performed 
in a university hospital dedicated to cardiology from 
January 2000 through July 2006. Were selected patients 
who had one of the following diagnoses: heart failure, 
cardiomyopathy, or cardiogenic shock in the autopsy 
report. Were excluded patients who underwent surgical 
or percutaneous cardiac interventions during the hospital 
admission in which death occurred, patients under 18 years 
of age or with congenital heart diseases, and patients with 
pericardial diseases. 
Altogether, 595 autopsies reports were included in 
the study and were further analyzed, searching for data as 
sex, age, arterial hypertension, diabetes mellitus, cause 
of death, heart failure etiology, left ventricular ejection 
fraction and the occurrence of a thromboembolic event.
The events were classified based on their contribution 
to the patient’s death mechanism according to previous 
criteria:9, 10  (1) events that were deemed to be the cause of 
death, (2) events related or contributors to death process, 
and (3) events unrelated to death. The cause of death was 
defined as the condition that led directly to death, excluding 
final events of a terminal disease. Diseases related to death 
were defined as contributing conditions to the primary cause 
253
Macedo IS, et al. Thromboembolic findings in patients with heart failure at autopsy.
of death, complications of the primary cause of death, or 
other diseases that contributed to death. Events classified 
as unrelated to death were defined as those who had no 
contribution to death mechanism.
In the study, we sought to investigate the occurrence 
of thromboembolic events in patients who had undergone 
autopsy. The main finding of our study is that patients with 
heart failure have a high frequency of thromboembolic 
events (39.2%) at autopsy, and many patients had more 
than a single event (1.6 events per patient); importantly, 
thromboembolic events were frequently associated with the 
death process. Further, we identified female sex and Chagas 
etiology as independent risk factors for the occurrence of 
thromboembolisms. Our findings are derived from a large 
population of heart failure patients submitted to autopsy 
including different etiologies.
Taken together,  our results indicate that 
thromboembolic events are frequent in patients with heart 
failure who have undergone autopsy and are frequently 
associated with the death process. Our findings have 
significant clinical implications as they warrant a high 
degree of suspicion for these occurrences, especially during 
the care of more susceptible populations such as women 
and Chagas patients.
REFERENCES
1. Howell MD1, Geraci JM, Knowlton AA. Congestive heart 
failure and outpatient risk of venous thromboembolism: 
a retrospective, case-control study. J Clin Epidemiol. 
2001;54 :810-6 .  h t tps : / /do i .o rg /10 .1016/S0895-
4356(00)00373-5.
2. Davis CJ1, Gurbel PA, Gattis WA, Fuzaylov SY, Nair GV, 
O’Connor CM, Serebruany VL. Hemostatic abnormalities in 
patients with congestive heart failure: diagnostic significance 
and clinical challenge. Int J Cardiol. 2000;75:15-21. https://
doi.org/10.1016/S0167-5273(00)00300-4.
3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as 
an independent risk factor for stroke: the Framingham 
Study. Stroke. 1991;22:983-8. https://doi.org/10.1161/01.
STR.22.8.983.
4. Waller BF1, McLaughlin T, Grider L, Rohr TM, Taliercio CP, 
Fetters J. Intracardiac thrombi: frequency, location, etiology, 
and complications: a morphologic review - Part III. Clin 
Cardiol. 1995;18:587-90.  doi: 10.1002/clc.4960181012. 
5. Blankenhorn MA. A critical consideration of the value of post 
mortem examination. Hospitals. 1938;12:30-2.
6. Wittschieber D, Klauschen F, Kimmritz AC, Winterfeld M, 
Kamphues C, Scholman HJ, Erbersdobler A, Pfeiffer H, 
Denkert C, Dietel M, Weichert W, Budczies J, Stanzinger A. 
Who is at risk for diagnostic discrepancies? Comparison of 
pre- and postmortal diagnoses in 1800 patients of 3 medical 
decades in East and West Berlin. PLoS One. 2012;7:e37460. 
https://doi.org/10.1371/journal.pone.0037460.
7. Issa VS, Dinardi LF, Pereira TV, de Almeida LK, Barbosa TS, 
Benvenutti LA, Ayub-Ferreira SM, Bocchi EA. Diagnostic 
discrepancies in clinical practice: an autopsy study in patients 
with heart failure. Medicine (Baltimore). 2017;96:e5978. doi: 
10.1097/MD.0000000000005978.
8. Nemetz PN, Tanglos E, Sands LP, Fisher WP Jr, Newman 
WP III, Burton EC. Attitudes toward the autopsy – an 8-state 
survey. Med Gen Med. 2006;8:80. Available from: https://
www.ncbi.nlm.nih.gov/pmc/articles/PMC1781284/.
9. Goldman L, Sayson R, Robbins S, Cohn LH, Bettmann 
M, Weisberg M. The value of the autopsy in three medical 
eras. N Engl J Med. 1983;308:1000-5. DOI: 10.1056/
NEJM198304283081704.
10. Battle RM, Pathak D, Humble CG, Key CR, Vanatta PR, 
Hill RB, Anderson RE. Factors influencing discrepancies 
between premortem and postmortem diagnoses. JAMA. 
1987;258:339-44. doi: 10.1001/jama.1987.03400030055031.
Submitted in: November, 24, 2017
Accepted in: December, 22, 2017
